CDKN2A and pancreatic intraductal papillary-mucinous neoplasm: Promoter methylation of at least one tumor suppressor gene can be demonstrated in IPMN [56], particularly p16 and p73; and IPMN with invasive carcinoma showed a higher rate of aberrant tumor suppressor gene methylation.